SEARCH RESULTS FOR: （薇信11008748）推特微密圈Onlyfans推荐大啵G奶御姐喵了个眯儿道具自慰炮机爆操爽晕了.dxl(16209 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
TRAY, BMET-11ANL, F/G
PN 74075-02M
RANFAC CORP.
11 Gauge x 4"
In Commercial Distribution
- M9797407502M9 ()
- M9797407502M0 ()
- Needle Gauge: 11 Gauge
- Length: 4 Inch
BMET-11ANL
- Bone marrow biopsy procedure kit
BMET-11A, F/G
PN 74075-01M
RANFAC CORP.
11 GAUGE x 4"
In Commercial Distribution
- M9797407501M9 ()
- M9797407501M0 ()
- Length: 4 Inch
- Needle Gauge: 11 Gauge
BMET-11A
- Bone marrow biopsy procedure kit
Pak12G assay is a qualitative solid phase enzyme linked immunosorbent assay (ELISA) designed to detect IgG antibodies to HLA class I antigens and to epitopes on the platelet glycoproteins IIb/IIIa, Ia/IIa, and Ib/IX.
IMMUCOR GTI DIAGNOSTICS, INC.
PAK12G
Not in Commercial Distribution
- 10888234500223 ()
PAK12G
- Human platelet antigen (HPA) multiple antibody screening/identification IVD, kit, enzyme immunoassay (EIA)
No Description
G21 SRL
611-01-140
In Commercial Distribution
- 08058964729026 ()
- Orthopaedic cement, antimicrobial
No Description
G21 SRL
610-01-140
In Commercial Distribution
- 08058964729019 ()
- Orthopaedic cement, antimicrobial
Contains VT601US(ES,VS×2), 4 of cryotopUSs(Green)and Repro Plate
KITAZATO CORPORATION
VT601US-TOP(G)
In Commercial Distribution
- 24582231462616 ()
- 14582231462596 ()
- IVF medium kit
Surgical Handpiece for 3I
W & H Dentalwerk Bürmoos GmbH
10207564
Not in Commercial Distribution
- J021102075641 ()
- Dental surgical power tool motorized handpiece/set, electric
Surgical Handpiece
W & H Dentalwerk Bürmoos GmbH
00001120
Not in Commercial Distribution
- J021000011201 ()
- Dental surgical power tool motorized handpiece/set, electric
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing CERAMENT G can also reduce the likelihood of infection subsequent to an open fracture.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system. In bone infection, CERAMENT G can also be inserted as pre-set beads.
Bone Support AB
A0535-06
In Commercial Distribution
- 07350055430530 ()
- Total Volume: 5 Milliliter
- Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft.
CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate.
By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing CERAMENT G can also reduce the likelihood of infection subsequent to an open fracture.
By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation.
The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection.
CERAMENT G may be implanted by an injectable system. In bone infection, CERAMENT G can also be inserted as pre-set beads.
Bone Support AB
A0535-05
In Commercial Distribution
- 07350055430523 ()
- Total Volume: 10 Milliliter
- Bone matrix implant, synthetic, antimicrobial